先端ロボット・内視鏡手術学

Medicine & Life Sciences

1. Gastrectomy 100%
2. Stomach Neoplasms 75%
3. Robotics 65%
4. Stomach 35%
5. Lymph Node Excision 32%
6. Liver 29%
7. Rectal Neoplasms 28%
8. Esophagectomy 27%
9. Laparoscopy 26%
10. Neoplasms 26%
11. Japan 21%
12. Carcinoma 20%
13. Recurrence 18%
14. Neoplasm Metastasis 18%
15. Orotate Phosphoribosyltransferase 18%
16. Pancreatectomy 18%
17. Drug Therapy 17%
18. Lymph Nodes 16%
19. Propensity Score 16%
20. Dissection 16%
21. Minimally Invasive Surgical Procedures 13%
22. Hepatic Veins 13%
23. Retrospective Studies 13%
24. Surgeons 12%
25. Colorectal Neoplasms 12%
26. Esophageal Neoplasms 12%
27. Pancreaticoduodenectomy 12%
28. Colonic Neoplasms 11%
29. Cohort Studies 10%
30. Hepatectomy 10%
31. Gastrointestinal Stromal Tumors 10%
32. Operative Time 10%
33. Colectomy 9%
34. Postoperative Complications 9%
35. Fluorouracil 9%
36. Hepatocellular Carcinoma 9%
37. Morbidity 9%
38. Capsules 9%
39. Chemoradiotherapy 9%
40. Multicenter Studies 8%
41. Segmental Mastectomy 8%
42. Therapeutics 8%
43. Pancreatic Neoplasms 7%
44. Abdomen 7%
45. Esophageal Squamous Cell Carcinoma 7%
46. Margins of Excision 7%
47. Cisplatin 7%
48. Survival 7%
49. Dihydrouracil Dehydrogenase (NADP) 7%
50. Thymidylate Synthase 6%
51. Gastroenterostomy 6%
52. Length of Stay 6%
53. Esophagus 6%
54. Arteries 6%
55. Vocal Cord Paralysis 6%
56. Rectum 6%
57. Adjuvant Chemotherapy 6%
58. Pancreas 5%
59. Survival Rate 5%
60. Hemorrhage 5%
61. Pathologic Constriction 5%
62. Prone Position 5%
63. Pancreatic Fistula 5%
64. Anastomotic Leak 5%
65. Adenocarcinoma 5%
66. Sigmoid Neoplasms 5%
67. Pancreaticojejunostomy 5%
68. Prolapse 5%
69. Colostomy 5%
70. Safety 5%
71. Anatomy 5%
72. Imatinib Mesylate 5%
73. Gastric Stump 5%